Research and Development

Long-COVID subtypes may help stratify patients, inform treatment strategies: Study

January 27, 2023

Consortium nabs $10M European grant to develop drug response tests for CKD

The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.

January 26, 2023

Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant

XBB.1.5 is prevalent in the U.S. and is quickly spreading to other countries. It is a subvariant of a SARS-CoV-2 variant called XBB. That lineage is a recombinant of two descendants of the BA.2 lineage, which began spiking early in 2022.

January 26, 2023

Unilabs, Ambry Genetics to provide genetic testing for biopharma firms in Europe, Latin America, Middle East

The companies aim to address one of the main challenges to the use of genomics in global clinical trials: a lack of standardization in laboratory testing protocols and analysis.

January 26, 2023

Probe measures cell stiffness and traction

Seeking ways to alter the probe's mechanical characteristics after injecting it into a tissue of interest, the researchers settled on hydrogels made of polyethylene glycol, a material approved for human use.

January 25, 2023

DNA tests show that mystery inflammatory syndrome may not be so rare

Physicians need to add VEXAS syndrome to the list of potential diagnoses when they see patients with persistent and unexplained inflammation and low blood cell counts, or anemia, the lead investigator of a new study said.

January 24, 2023

Most Popular

COVID-19 immune response strengthens over time: Study

Cardiovascular disease deaths undergo largest single-year increase since 2015

California sisters plead guilty in $7.5M Medicare fraud involving phlebotomy services

Study: One-third of ‘mostly young and healthy’ people develop long COVID symptoms

Roche launches COVID-19 PCR test to detect fast-spreading XBB.1.5 Omicron subvariant

AI tool makes speedy gene-editing possible, offers alternative to CRISPR

S2 Genomics, Bonsailab ink Spain, Portugal distribution agreement

S2 Genomics is partnering with Bonsailab to promote, sell, and support its Singulator 100 and 200 systems, which provide consistent isolation of single cells or nuclei from solid-tissue samples.

January 17, 2023

After Illumina presentation highlighting Grail potential comes a possible EU fine

At the J.P. Morgan healthcare event this week, Illumina's CEO said Grail must be operated separately and independently pursuant to measures required by the EU.

January 12, 2023

Foundation Medicine, Natera launch tumor DNA monitoring assay

FoundationOne Tracker may complement imaging to better assess treatment response and inform next steps, particularly when imaging is ambiguous.

January 11, 2023

Grail launches methylation-based liquid biopsy solution for cancer research in a post-diagnosis setting

Potential research use cases include prognosis, minimal residual disease detection, and recurrence monitoring across different cancer types in research studies, the firm said.

January 10, 2023

Quanterix expands laboratory-developed-test menu with launch of neurofilament light chain test

The blood test expands access to an important brain health biomarker to advance research and clinical care, the firm said.

January 10, 2023

Agilent Technologies, Akoya Biosciences partner to develop multiplex immunohistochemistry assays for tissue analysis

The firms are collaborating to commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development.

January 6, 2023

Page 1 of 28

Next Page